Total Payments
$74,085
2024 Payments
$10,177
Companies
21
Transactions
259
Medicare Patients
827
Medicare Billing
$197,799
Payment Breakdown by Category
Other$61,440 (82.9%)
Food & Beverage$11,236 (15.2%)
Travel$1,363 (1.8%)
Education$46.31 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $61,440 | 26 | 82.9% |
| Food and Beverage | $11,236 | 210 | 15.2% |
| Travel and Lodging | $1,363 | 18 | 1.8% |
| Education | $46.31 | 5 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $66,877 | 163 | $0 (2024) |
| Amgen Inc. | $1,935 | 16 | $0 (2024) |
| ABBVIE INC. | $770.56 | 21 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $767.68 | 6 | $0 (2023) |
| Amarin Pharma Inc. | $654.97 | 8 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $640.11 | 6 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $540.32 | 7 | $0 (2019) |
| Novo Nordisk Inc | $387.34 | 3 | $0 (2022) |
| Allergan Inc. | $210.93 | 7 | $0 (2019) |
| Nestle HealthCare Nutrition Inc. | $204.81 | 5 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $10,177 | 27 | Gilead Sciences, Inc. ($9,579) |
| 2023 | $13,592 | 28 | Gilead Sciences, Inc. ($13,058) |
| 2022 | $8,949 | 25 | Gilead Sciences, Inc. ($7,828) |
| 2021 | $8,753 | 23 | Gilead Sciences, Inc. ($7,787) |
| 2020 | $4,824 | 20 | Gilead Sciences, Inc. ($4,311) |
| 2019 | $6,446 | 30 | Gilead Sciences, Inc. ($5,492) |
| 2018 | $10,001 | 54 | Gilead Sciences, Inc. ($8,481) |
| 2017 | $11,343 | 52 | Gilead Sciences Inc ($10,340) |
All Payment Transactions
259 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $28.96 | General |
| 12/03/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $27.76 | General |
| Category: LIVER DISEASE | ||||||
| 10/30/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $24.87 | General |
| 10/17/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Bone Health | ||||||
| 10/08/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $25.42 | General |
| Category: LIVER DISEASE | ||||||
| 10/07/2024 | Gilead Sciences, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,830.00 | General |
| 10/07/2024 | Gilead Sciences, Inc. | — | Travel and Lodging | In-kind items and services | $20.10 | General |
| 10/03/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $13.35 | General |
| 09/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: DIABETES | ||||||
| 09/09/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $30.18 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/21/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $27.85 | General |
| 07/08/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $30.88 | General |
| 05/16/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $123.96 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/23/2024 | Gilead Sciences, Inc. | Vemlidy (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,830.00 | General |
| Category: HBV | ||||||
| 04/23/2024 | Gilead Sciences, Inc. | Vemlidy (Drug) | Travel and Lodging | In-kind items and services | $25.10 | General |
| Category: HBV | ||||||
| 04/18/2024 | Gilead Sciences, Inc. | Vemlidy (Drug) | Food and Beverage | In-kind items and services | $106.80 | General |
| Category: HBV | ||||||
| 04/17/2024 | Gilead Sciences, Inc. | Vemlidy (Drug) | Travel and Lodging | In-kind items and services | $101.79 | General |
| Category: HBV | ||||||
| 04/17/2024 | Gilead Sciences, Inc. | Vemlidy (Drug) | Travel and Lodging | In-kind items and services | $100.00 | General |
| Category: HBV | ||||||
| 04/10/2024 | Gilead Sciences, Inc. | Vemlidy (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,240.00 | General |
| Category: HBV | ||||||
| 04/10/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $29.33 | General |
| 04/02/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $29.63 | General |
| 03/25/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $29.99 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/21/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $110.58 | General |
| Category: Bone Health | ||||||
| 03/15/2024 | Gilead Sciences, Inc. | Vemlidy (Drug) | Food and Beverage | In-kind items and services | $42.85 | General |
| Category: HBV | ||||||
| 03/15/2024 | Gilead Sciences, Inc. | Vemlidy (Drug) | Food and Beverage | In-kind items and services | $37.32 | General |
| Category: HBV | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 125 | 131 | $73,170 | $28,650 |
| 2022 | 4 | 182 | 194 | $99,690 | $42,944 |
| 2021 | 7 | 344 | 361 | $200,425 | $89,043 |
| 2020 | 4 | 176 | 186 | $88,025 | $37,163 |
Total Patients
827
Total Services
872
Medicare Billing
$197,799
Procedure Codes
18
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Office | 2023 | 54 | 56 | $44,520 | $19,781 | 44.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 58 | 62 | $12,400 | $4,650 | 37.5% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Office | 2023 | 13 | 13 | $16,250 | $4,219 | 26.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Office | 2022 | 66 | 68 | $54,060 | $26,229 | 48.5% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Office | 2022 | 22 | 22 | $27,500 | $7,624 | 27.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 73 | 83 | $14,150 | $6,777 | 47.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 21 | 21 | $3,980 | $2,313 | 58.1% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Office | 2021 | 117 | 119 | $94,605 | $46,514 | 49.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 107 | 113 | $20,340 | $13,416 | 66.0% |
| 45378 | Diagnostic examination of the colon (large bowel) using an endoscope(colonoscopy); high risk | Office | 2021 | 24 | 24 | $30,000 | $8,258 | 27.5% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Office | 2021 | 20 | 20 | $25,500 | $7,307 | 28.7% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Office | 2021 | 14 | 14 | $18,130 | $6,553 | 36.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 50 | 59 | $8,850 | $5,030 | 56.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 12 | 12 | $3,000 | $1,964 | 65.5% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Office | 2020 | 57 | 57 | $45,315 | $21,154 | 46.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 75 | 82 | $14,760 | $8,053 | 54.6% |
| 45378 | Diagnostic examination of large bowel using an endoscope | Office | 2020 | 19 | 19 | $23,750 | $6,085 | 25.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 25 | 28 | $4,200 | $1,871 | 44.5% |
About Dr. Chang Ho Suk, MD
Dr. Chang Ho Suk, MD is a Gastroenterology healthcare provider based in Flushing, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1447316104.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Chang Ho Suk, MD has received a total of $74,085 in payments from pharmaceutical and medical device companies, with $10,177 received in 2024. These payments were reported across 259 transactions from 21 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($61,440).
As a Medicare-enrolled provider, Suk has provided services to 827 Medicare beneficiaries, totaling 872 services with total Medicare billing of $197,799. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Flushing, NY
- Active Since 12/28/2006
- Last Updated 07/08/2007
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1447316104
Products in Payments
- Vemlidy (Drug) $45,413
- Prolia (Biological) $976.33
- JARDIANCE (Drug) $738.51
- EVENITY (Biological) $714.81
- Vascepa (Drug) $654.97
- ZENPEP (Drug) $390.76
- CREON (Drug) $381.06
- TAGRISSO (Drug) $380.04
- Creon (Drug) $327.44
- IMFINZI (Drug) $252.80
- Repatha (Biological) $243.74
- ELIQUIS (Drug) $226.38
- STEGLATRO (Drug) $187.45
- VOQUEZNA (Drug) $184.13
- ZEPATIER (Drug) $156.30
- RYBELSUS (Drug) $147.06
- IMFINZI (Biological) $134.84
- IBSRELA (Drug) $125.00
- Ozempic (Drug) $125.00
- Revlimid (Drug) $124.13
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Flushing
Stephen Esposito, Md, MD
Gastroenterology — Payments: $247,830
Gastroenterology $247,830
Dr. Jianlin Xie, M.d, M.D
Gastroenterology — Payments: $117,070
Gastroenterology $117,070
Joon Myung, Md, MD
Gastroenterology — Payments: $48,959
Gastroenterology $48,959
Dr. Sang Kim, M.d, M.D
Gastroenterology — Payments: $39,975
Gastroenterology $39,975
Sing Chan, M.d, M.D
Gastroenterology — Payments: $24,167
Gastroenterology $24,167
Dr. Constantine Fisher, Md, MD
Gastroenterology — Payments: $15,113
Gastroenterology $15,113